Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 5 EP applications Jonathan Paul Wood has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 18, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12738608

SOLUBLE PROTEINS FOR USE AS THERAPEUTICS

IPC classification:
A61K 38/17, C07K 14/705, C07K 16/24, C07K 16/44, C07K 19/00
Applicant:
Novartis AG
Agent:
Jonathan Paul Wood, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12821311

COMPOSITIONS AND METHODS FOR ANTIBODIES TARGETING FACTOR P

IPC classification:
C07K 16/18
Applicant:
Novartis AG
Agent:
Jonathan Paul Wood, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP14175571

Compositions and methods for antibodies targeting complement protein C5

IPC classification:
A61K 39/395, C07K 16/18
Applicant:
Novartis AG
Agent:
Jonathan Paul Wood, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP14175574

Compositions and methods for antibodies targeting complement protein C5

IPC classification:
A61K 39/395, C07K 16/18
Applicant:
Novartis AG
Agent:
Jonathan Paul Wood, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11766979

ANTI-IL12RBETA1 ANTIBODIES AND THEIR USE IN TREATING AUTOIMMUNE AND INFLAMMATORY DISORDERS

IPC classification:
C07K 16/28
Applicant:
Novartis AG
Agent:
Jonathan Paul Wood, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN

Please Sign in to use this feature